REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
16/06/2025
Voltar para busca
Dado oficial do USPTO
SCIENTUS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SCIENTUS
ST13
US500000087408833Classe
5, 35, 36, 41, 42, 44
Pedido
87408833
Registro
6077380
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
17/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 36, 41, 42, 44
Data de depósito
20/12/2018
Data de registro
16/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/06/2020
Última transação
17/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Toronto, Ontario, CA
Examinador
BEN, LINDSEY
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Scientus Pharma Inc.
Representantes
Rebecca L. Wilson THE DOBRUSIN LAW FIRM, PC
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 36Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Herbs for medicinal purposes; Medicinal oils; Plant extracts for pharmaceutical purposes; Pure extracts of medicinal plants and herbsplant extracts for medical purposes; Pharmaceutical and veterinary preparationsherbsherbal extractsformulas containing herbal extractsmedicinal oils and pure extracts of medicinal plants and herbs; all of the aforementioned containing a delta-9 THC concentration of not more than 0.3% on a dry weight basis and also not containing CBD
Classe 35
Promoting public awareness of the need for assuring patients safe access to affordable medical cannabis by means of public advocacy; Business consulting services; Business management consulting and advisory services; Business development consulting services; Business consultation services in the field of cannabis; Online medical cannabis resourcesproviding online consumer information related to medical cannabis
Classe 36
Financial consultation services related to the sellinguse and application of cannabis and cannabis related products
Classe 41
Providing information and news in the field of current events relating to cannabis; Providing health and wellness education in the field of medical cannabis for patients and providers through courses and the distribution of printed materials in connection therewith; Providing an internet website portal that provides enlightening and entertaining content focusing on current events information and commentary relating to the cannabis culture and lifestyle via personal interviewshumorous videos and factual information; Providing an Internet website portal featuring news and commentary in the field of current events reporting on the subjects of marijuanamedical marijuanahemp and industrial hemp; entertainment services in the nature of continuing audio/visual programs in the fields of marijuanamedical marijuanahemp and industrial hemp distributed via the Internetsatelliteradiotelevisioncellular telephone and social media platforms; Providing information about entertainment and cultural events related to cannabismarijuana and hemp
Classe 42
Biopharmaceutical product development and research and developmentall of the aforementioned for products containing a delta-9 THC concentration of not more than 0.3% on a dry weight basis
Classe 44
Providing health and wellness educational information in the field of medical cannabis for patients and providers through web-based applications and videos
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
16/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/03/2020
PUBO
PUBLISHED FOR OPPOSITION
31/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
24/02/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
21/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/01/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/07/2019
GNRT
NON-FINAL ACTION E-MAILED
30/07/2019
CNRT
NON-FINAL ACTION WRITTEN
30/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/07/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/01/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/06/2018
GNSL
LETTER OF SUSPENSION E-MAILED
07/06/2018
CNSL
SUSPENSION LETTER WRITTEN
07/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/05/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/05/2018
ALIE
ASSIGNED TO LIE
16/05/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/11/2017
GNRT
NON-FINAL ACTION E-MAILED
08/11/2017
CNRT
NON-FINAL ACTION WRITTEN
08/11/2017
DOCK
ASSIGNED TO EXAMINER
02/11/2017
DOCK
ASSIGNED TO EXAMINER
02/05/2017
MPMK
NOTICE OF PSEUDO MARK E-MAILED
20/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/04/2017
NWAP
NEW APPLICATION ENTERED
15/04/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SCIENTUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.